# Domperidone for Relief of Gastrointestinal Disorders

> **NCT00761254** · NA · TERMINATED · sponsor: **Carle Physician Group** · enrollment: 42 (actual)

## Conditions studied

- Gastroparesis
- GERD
- Esophagitis
- Dyspepsia
- Chronic Idiopathic Constipation
- Nausea
- Vomiting

## Interventions

- **DRUG:** Domperidone

## Key facts

- **NCT ID:** NCT00761254
- **Lead sponsor:** Carle Physician Group
- **Sponsor class:** INDIV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-08
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 42 (ACTUAL)
- **Why stopped:** PI withdrew due to increased responsibilities in clinical department.
- **Last updated:** 2012-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00761254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00761254, "Domperidone for Relief of Gastrointestinal Disorders". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00761254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*